OUR INSTITUTES: CANCER | HEART | NEUROSCIENCE | ORTHOPAEDICS
 
 

CHOC Pressroom
Share |
Printer Friendly
CHOC CHILDREN'S DR. LEONARD SENDER NAMED EDITOR-IN-CHIEF OF GROUNDBREAKING JOURNAL FOCUSED ON PROVIDING CARE FOR ADOLESCENT AND YOUNG ADULT CANCER PATIENTS
May 13, 2011

The Journal of Adolescent and Young Adult Oncology (JAYAO), a groundbreaking new peer-reviewed journal has been launched as part of a movement to transform cancer care and survivorship for adolescent and young adult (AYA) patients and survivors. The Journal is under the expert editorial leadership of founder and Editor-in-Chief Dr. Leonard S. Sender of CHOC Children’s and the University of California, Irvine. Specifically, Dr. Sender is the Medical Director of the CHOC Children’s Cancer Institute and Director of the Young Adult Cancer Program at the University of California, Irvine’s Chao Family Comprehensive Cancer Center. JAYAO is published by Mary Ann Liebert, Inc.

The field of adolescent and young adult oncology (AYAO) reflects the growing recognition that this group of patients and survivors are not just “old” pediatric patients or “young” adult patients. AYAs have treatment and survivorship-related issues and concerns unique to their age range, which the National Cancer Institute defines as 15-39 years old.

The Journal has a broad mandate and will be an essential resource for a multidisciplinary audience, including pediatric, adult, and surgical oncologists of all types and specialties; oncology nurses and advanced practice staff; psychosocial and supportive care providers including psychiatrists, psychologists, and social workers; translational cancer researchers; and academic and community-based pediatric and adult cancer institutions.

Newly diagnosed young adult cancer patients are often dealing with ongoing developmental and psychosocial issues in addition to their medical treatment. Further, pediatric cancer survivors who have ‘aged in’ to AYAO are a growing part of the AYA community, and survivorship is often fraught with the unintended consequences of cancer treatment, including infertility, heart and lung damage, and metabolic problems.

In addition to the Journal’s expert editorial leadership of Dr. Sender, the outstanding multidisciplinary international Editorial Board includes prominent associate editors and section editors representing the AYAO-relevant subspecialties of breast cancer, gastrointestinal oncology, gynecologic oncology, head and neck cancer, leukemia and lymphoma, melanoma, neuro-oncology, oncofertility, radiation oncology, testicular cancer, sarcoma, and psychosocial and survivorship issues.

“To truly advance care for this population, AYA oncology must be recognized as a distinct subspecialty, with a professional organization and publication to support it,” says Dr. Sender. “JAYAO is the culmination of this impetus, and is the Official Journal of the newly formed Society for Adolescent and Young Adult Oncology.”

The inaugural issue, available free online, provides a wide range of provocative articles and perspectives including review articles on acute lymphoblastic leukemia treatment and fertility preservation for patients with testicular cancer; original articles about the reproductive concerns of children and adolescents with cancer and survival rates in the most common AYA cancers; a Roundtable discussion with Archie Bleyer, MD and other trailblazers in the field; a Controversies feature about the definition of the AYAO age range; articles from leading Advocacy groups about their organizations and programs; a Clinical Trial Spotlight highlighting a trial with AYA-specific impacts; and a Point of View on palliative care for AYAs from pediatric practitioners. Voices of AYAO, stories from survivors, provides insight into these patients’ experiences and challenges.

 

About CHOC Children's: Named one of the best children’s hospitals by U.S. News & World Report (2013-2014) and a 2013 Leapfrog Top Hospital, CHOC Children's is exclusively committed to the health and well-being of children through clinical expertise, advocacy, outreach and research that brings advanced treatment to pediatric patients. Affiliated with the University of California, Irvine, CHOC’s regional healthcare network includes two state-of-the-art hospitals in Orange and Mission Viejo, several primary and specialty care clinics, a pediatric residency program, and four centers of excellence - The CHOC Children’s Heart, Neuroscience, Orthopaedic and Hyundai Cancer Institutes.

CHOC earned the Gold Level CAPE Award from the California Council of Excellence, the only children’s hospital in California to ever earn this distinction, and was awarded Magnet designation, the highest honor bestowed to hospitals for nursing excellence.  Recognized for extraordinary commitment to high-quality critical care standards, CHOC’s Pediatric Intensive Care Unit (PICU) is the first in the United States to earn the Pediatric Beacon Award for Critical Care Excellence.

###

Media Contact:
Monica Garcia, Sr. Public Relations Specialist
phone: (714) 289-4183
email: pr@chocchildrens.org

PEDIATRIC HEALTH LIBRARY
CENTERS:
RESEARCH INSTITUTE
HYUNDAI CANCER INSTITUTE
RELATED SERVICES:
HEM/ONC FELLOWSHIP
RELATED SPECIALTIES:
HEMATOLOGY
ONCOLOGY
RELATED LINKS:
FIND SPECIALISTS
ARTICLES
STORIES
NEWS
VIDEO
spacer

Facebook  Twitter  Pinterest  Instagram  Foursquare  LinkedIn  YouTube  RSS  CHOC Blog

US News     CAPE Award   Magnet      Beacon Award      Most Trusted Brand     Leapfrog

chocChildren's Hospital of Orange County | UCI University of California, Irvine

Children's Hospital of Orange County is affiliated with UC Irvine Healthcare and UC Irvine School of Medicine

CHOC Children's - 1201 W La Veta Ave, Orange, CA. Phone: 714-997-3000. .